Humanigen Investor Relations Material
Latest events
Q4 2022
30 Mar, 2023
Q4 2021
1 Mar, 2022
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Humanigen Inc
Access all reports
Humanigen Inc is a biopharmaceutical company developing therapies aimed at preventing and treating immune hyper-response conditions. The company’s research focuses on addressing inflammatory and infectious diseases. Humanigen operates within the healthcare and biotechnology sectors. The company is headquartered in Short Hills, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
HGEN
Country
🇺🇸 United States